Skip to main content
. 2015 Feb 25;19(3):651–663. doi: 10.1111/jcmm.12469

Fig 2.

Fig 2

Effects of 17-AAG on the expression of LATS1, p-LATS1, YAP and CTGF. (A and B) The mRNA expression levels of YAP and CTGF, indicated by Real-time PCR assay, were markedly decreased, while those of LATS1 and p-LATS1 were increased in 17-AAG treated groups for 24 hrs compared to the untreated group (each **P < 0.01). (C) The expression levels of YAP and CTGF proteins, indicated by Western blot assay, were down-regulated, while LATS1 was upregulated in a dose-dependent manner in 17-AAG treated groups compared to the untreated group.